Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Dr. R. Rox Anderson Joins Medical Advisory Board of Apogee Technology

Abstract:
Apogee Technology, Inc. (AMEX: ATA), an emerging micro-systems and nanotechnology company that designs, develops and commercializes medical devices and sensor products, reported today that Dr. R. Rox Anderson has agreed to join the Company's Medical Advisory Board. Dr. Anderson practices dermatology at Massachusetts General Hospital and is the Director of the Wellman Center for Photomedicine at Massachusetts General Hospital. In addition, Dr. Anderson is a Professor of Dermatology at Harvard Medical School and is an affiliated faculty member at the Massachusetts Institute of Technology (MIT).

Dr. R. Rox Anderson Joins Medical Advisory Board of Apogee Technology

NORWOOD, MA | Posted on March 22nd, 2007

Herbert Stein, Apogee's Chairman and Chief Executive Officer, said, "We are extremely excited to have a leading dermatologist supporting the development of our PyraDerm™ intradermal drug delivery platform. His expertise in the structure of the skin, the treatment of skin diseases and his medical technology development experience will be invaluable as we work towards the commercialization of our delivery solutions for FDA regulated and non regulated applications."

Dr. Anderson has conceived and developed dermatologic surgery using selectively absorbed laser pulses, which is now the preferred basis for treatment of birthmarks, pigmented lesions, tattoos, hypertrichosis and other conditions. He has made many contributions to the understanding and development of laser-tissue interactions, tissue optics, photodynamic therapy, and optical diagnostics. Dr. Anderson received his undergraduate degree from MIT and his M.D. from Harvard Medical School.

####

About Apogee Technology, Inc.
Apogee Technology designs, develops and commercializes proprietary medical device and sensor products using its MEMS and nanotechnology for the medical, automotive, industrial and consumer markets. The Company is developing its PyraDerm™ solution for enhanced intradermal drug delivery and has introduced a family of pressure sensors under the Sensilica® brand. Apogee's goal is to provide value-added and cost-saving solutions for our customers and, in so doing, become a global leader in the sensor and medical device fields. For more information please visit our web site at: http://www.apogeemems.com .

PyraDerm™ and Sensilica® are trademarks of Apogee Technology, Inc. All other product names noted herein may be trademarks of their respective holders. Certain statements made herein that use the words "anticipate," "hope," "estimate," "project," "will," "intend," "plan," "expect," "believe" and similar expressions are intended to identify forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve known and unknown risks and uncertainties, which could cause the actual results, performance or achievements of the Company to be materially different from those that may be expressed or implied. Please refer to the company's risk factors as set forth in the Company's filings with the Securities and Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.

For more information, please click here

Contacts:
Kelly Black
Premier Funding & Financial Marketing
480-649-8224

Copyright © Market Wire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Sensors

Promising new method for rapidly screening cancer drugs: UMass Amherst researchers invent fast, accurate new nanoparticle-based sensor system December 15th, 2014

Graphene Applied in Production of Recyclable Electrodes December 13th, 2014

Detecting gases wirelessly and cheaply: New sensor can transmit information on hazardous chemicals or food spoilage to a smartphone December 8th, 2014

Nanosensor to Detect Naproxen Drug Produced in Iran December 6th, 2014

Announcements

Silicon Valley-Based Foresight Valuation Launches STR-IP™, a New Initiative for Startups to Discover the Value of Their Intellectual Property December 18th, 2014

Iranian Scientists Use Nanotechnology to Increase Power, Energy of Supercapacitors December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

First Home-Made Edible Herbal Nanodrug Presented to Pharmacies across Iran December 17th, 2014

Appointments/Promotions/New hires/Resignations/Deaths

Nanomedicine expert joins Rice faculty: Gang Bao combines genetic, nano and imaging techniques to fight disease December 17th, 2014

Nexeon Attracts ex-Nokia Product Executive to its Board of Directors December 15th, 2014

Arrowhead Appoints Patrick O'Brien as General Counsel December 4th, 2014

Mining entrepreneur Julian Malnic Joins Deep Space Industries’ Board: Deep Space Industries welcomes a prolific mining entrepreneur and accomplished company builder, Julian Malnic, to its Board of Directors November 14th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE